The tocotrienol-rich fraction from rice bran enhances cisplatin-induced cytotoxicity in human mesothelioma H28 cells

Phytotherapy Research

Volumn 24, Issue 9, 2010, Pages 1317-1321

  Nakashima, Keisuke ^a   Virgona, Nantiga ^a,b   Miyazawa, Mio ^a   Watanabe, Takashi ^c   Yano, Tomohiro ^a  

^a NATIONAL INSTITUTE OF HEALTH AND NUTRITION   (Japan)

^b UNIVERSITY OF SYDNEY   (Australia)

^c 1 Numata Kitagata cho   (Japan)

Author keywords

tocotrienol; Chemoresistance; Cisplatin; Mesothelioma; PI3K AKT

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; CISPLATIN; GAMMA TOCOTRIENOL; PHOSPHATIDYLINOSITOL 3 KINASE; TOCOTRIENOL RICH FRACTION; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CELL VIABILITY; CHEMOSENSITIVITY; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; HUMAN; HUMAN CELL; MESOTHELIOMA; RICE BRAN;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL LINE, TUMOR; CELL SURVIVAL; CHROMANS; CHROMONES; CISPLATIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, NEOPLASM; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; HUMANS; MESOTHELIOMA; MORPHOLINES; ORYZA SATIVA; PHOSPHATIDYLINOSITOL 3-KINASE; PHYTOTHERAPY; PLANT EXTRACTS; PROTO-ONCOGENE PROTEINS C-AKT; SEEDS; SIGNAL TRANSDUCTION; VITAMIN E;

EID: 77957258791     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.3107     Document Type: Article

References (14)

1. Carbone M, Kratzke RA, Testa JR. 2002. The pathogenesis of mesothelioma. Seminars in Oncology 29(1): 2-17.
2. Clark AS, West K, Streicher S, Dennis PA. 2002. Constitutive and inducible Akt activity promotes resistance to chemotherapy, trastuzumab, or tamoxifen in breast cancer cells. Mol Cancer Ther 1: 707-717.
3. Fujiwara M, Izuishi K, Sano T, Hossain MA, Kimura S, Masaki T, Suzuki Y. 2008. Modulating effect of the PI3-kinase inhibitor LY294002 on cisplatin in human pancreatic cancer cells. J Exp Clin Cancer Res 27: 76-84.
4. Hayakawa J, Ohmichi M, Kurachi H, Kanda Y, Hisamoto K, Nishio Y, Adachi K, Tasaka K, Kanzaki T, Murata Y. 2000. Inhibition of BAD phosphorylation either at serine 112 via extracellular signal-regulated protein kinase cascade or at serine 136 via Akt cascade sensitizes human ovarian cancer cells to cisplatin. Cancer Res 60: 5988-5994.
5. Iwasaki T, Machihara M, Iwasa T, Kimura J. 1982. Pharmacokinetic studies on cis-diamminedichloroplatinum administered to a patient with ovarian embryonal carcinoma. J Exp Clin Medicine (IGAKU NO AYUMI) 121: 963-965.
6. Liu P, Cheng H, Roberts TM, Zhao JJ. 2009. Targeting the phosphoinositide 3-kinase pathway in cancer. Nat Rev Drug Discov 8: 627-644.
7. Nowak AK, Lake RA, Kindler HL, Robinson BW. 2002. New approaches for mesothelioma: biologics, vaccines, gene therapy, and other novel agents. Seminars in Oncology 29: 82-96.
8. Rasool AH, Yuen KH, Yusoff K, Wong AR, Rahman AR. 2006. Dose dependent elevation of plasma tocotrienol levels and its effect on arterial compliance, plasma total antioxidant status, and lipid profile in healthy humans supplemented with tocotrienol rich vitamin E. J Nutr Sci Vitaminol 52: 473-478.
9. Sen CK, Khanna S, Roy S. 2007. Tocotrienols in health and disease: the other half of the natural vitamin E family. Mol Aspects Med 28: 692-728. (Pubitemid 47625534)
10. Shah SJ, Sylvester PW. 2005. Gamma-tocotrienol inhibits neoplastic mammary epithelial cell proliferation by decreasing Akt and nuclear factor kappaB activity. Exp Biol Med 230: 235-241.
11. Siddik ZH. 2003. Cisplatin: mode of cytotoxic action and molecular basis of resistance. Oncogene 22: 7265-7279.
12. Suzuki Y, Murakami H, Kawaguchi K, Taniguchi T, Fujii M, Shinjo K, Kondo Y, Osada H, Shimokata K, Horio Y, Hasegawa Y, Hida T, Sekido Y. 2009. Activation of the PI3K-AKT pathway in human malignant mesothelioma cells. Mol Med Rep 2: 181-188.
13. Tomek S, Emri S, Krejcy K, Manegold C. 2003. Chemotherapy for malignant pleural mesothelioma: past results and recent developments. British Journal of Cancer 88: 167-174. (Pubitemid 36258399)
14. Yano T, Virgona N. 2008. Anticancer effects of tocotrienols and tocopherols irrespective of antioxidant properties. In Tocotrienols: Vitamin E beyond Tocopherols, Watson RR, Preedy VR (eds). CRC Press: Boca Raton, FL; 171-183.